Abacus Life And Lorisco Life Announce Launch Of Preadisan To Improve Health Predictions By Investing.com

Abacus Life and Lorisco Life have partnered to launch a new product, PREADISAN, which uses blood-based proteomic biomarker analysis and AI models to assess mortality risks and provide personalized health predictions. This partnership combines Abacus’ expertise in life settlements and actuarial technology with Lorisco’s cutting-edge health prediction platform.